Can You Sell a Screenplay Based on a True Story? Rights, Explained

Can You Sell a Screenplay Based on a True Story Without Permission?

Yes. Can you sell a screenplay based on a true story without a signature from the person who lived it? Often, yes, and writers who assume otherwise talk themselves out of the most commercially interesting material they will ever have. Copyright does not protect facts. Historical events, biographical details, research findings, news of the day: none of it is owned by anybody. Living through something remarkable does not create a copyright in having lived through it.

The complication is that selling a script and getting a film distributed are two transactions with two risk profiles. A producer can option your spec on a Monday. Whether a distributor releases the finished film depends on whether an insurance underwriter is comfortable with the rights position much later, often long after the option was signed. Everything hard about true story material lives in that gap.

The exposure is not copyright. It is three bodies of law that have nothing to do with owning a story: defamation, invasion of privacy, and the right of publicity. Behind all three sits a fourth gate most writers never think about until it stalls a deal: errors and omissions insurance.

So the answer is layered. You can write it. You can sell it. Whether it gets produced without a clearance fight depends on who your subject is, whether they are alive, what state they lived in, how recognizable your version is, and how carefully you documented every damaging beat. What follows is the mechanics: what life rights buy, what the case law decided, what E&O covers, and how to build a clearable spec.

What Life Rights Actually Are (and What They Aren't)

"Life rights" is a term of art for something you cannot literally buy. Nobody owns their biography the way a novelist owns a novel. A life story agreement bundles releases and promises into one option and purchase contract: the grant covers the right to develop a screenplay, produce a film, and distribute and exhibit it based on the subject's life, drafted around the personal nature of the rights rather than treating them like a literary property.

Strip away the mystique and the buyer purchases three things. Protection: a covenant not to sue for defamation, invasion of privacy, or violation of the right of publicity. Cooperation: the subject sits for interviews, supports the project publicly, and does not set up a competing version across town. Access: diaries, letters, photographs, private correspondence, the material unavailable to anyone working from the public record alone.

The third item is the one worth paying for creatively. The first is what buyers pay for commercially.

Scope is where the negotiation gets long. A serious agreement addresses whether the grant reaches remakes, sequels, television series, merchandise, novelizations, stage adaptations, radio, and worldwide distribution. Buyers push for the broadest scope, every time.

On price, nobody credible will give you a standard number. What is documented is the structure. Option payments span an enormous range: the rule of thumb of roughly 10 percent of the eventual purchase price, several million dollars for a bestselling book, or nominal one dollar arrangements, the model Stephen King popularized with his Dollar Baby program licensing short story rights to student and independent filmmakers. The window is commonly six months to one year, giving the producer exclusive time to attach talent or financing before deciding whether to exercise and buy the full rights.

For a private individual with no public demand for their story, both the option fee and the purchase price land at the low end, with no market pressure comparable to a celebrity or newsworthy public figure. Beyond a flat fee, compensation typically means points on net profits, a consulting fee, and bonuses tied to ancillary markets: sequels, merchandising, streaming.

If your subject is dead, the math changes but the conversation does not vanish. The dead cannot be defamed and cannot have their privacy invaded under the traditional common law torts, which removes two of the three exposures. Producers still pursue life rights style agreements with heirs and estates, for cooperation, for exclusive materials, and because publicity rights can descend to heirs depending on the state.

Facts Are Free: Why Copyright Isn't the Obstacle You Think It Is

Copyright protects expression, not information. It does not cover facts of any kind: scientific, historical, biographical, or news of the day. An author's original compilation, arrangement, or selection of facts can itself be protected, but the underlying facts stay free for anyone to use.

You can read every piece of reporting on a scandal, build a timeline, and write a screenplay from it without licensing a single article. What you cannot lift is the article's distinctive expression: its turns of phrase, its sequencing choices, its invented framing devices. Adapt the events, not the writing.

Writers get into trouble working from one long form piece and dramatizing its architecture beat for beat. If a fact appears only in one reporter's work, you are leaning on that reporter's selection and arrangement and relying on a single uncorroborated source for something a lawyer will eventually ask you to prove. Both problems have the same fix: go wider, and cite.

The Writers Guild draws the same line in its credit system. Under the WGA Screen Credits Manual, "source material" means previously published or exploited material assigned to a writer and forming the basis of their work: a novel, a produced play, a series of published articles, other non Guild literary material. It is credited separately from story, as "Based upon a Story by" or "From a Series of Articles by." A "Screen Story by" credit applies when a writer is given source material of a story nature and creates a substantially new and different story from it, using only limited elements such as a springboard, a characterization, or an incident. That credit has no percentage contribution requirement, cannot be shared by more than two writers, and must be awarded through arbitration.

Crucially, the manual treats biographical, newspaper, and other factual sources differently from narrative story sources, noting that factual material may not necessarily deprive the writer of full "Written by" credit. That is the fact and expression line wearing a different hat. One caution: the version carrying these provisions applies to notices of tentative writing credit submitted after November 12, 2018, and the Guild's new Minimum Basic Agreement took effect May 2, 2026 and runs through May 1, 2030. Confirm the current text before relying on any credit rule.

The Real Obstacle: Defamation and the Right of Publicity

Defamation is where true story projects actually get sued, and the variable that decides most of these cases is whether your subject is a public figure.

New York Times Co. v. Sullivan, decided in 1964, established that a public official suing for defamation must prove "actual malice": that the statement was made with knowledge it was false, or with reckless disregard for whether it was false. In 1967, Curtis Publishing Co. v. Butts and Associated Press v. Walker extended that standard to public figures generally, covering all purpose public figures with pervasive fame and limited purpose public figures, people who voluntarily entered a specific public controversy. Private figures face a materially lower bar, so actual malice attaches to public officials and public figures, not to everybody you put on the page.

Andrew Greene's suit over The Wolf of Wall Street is the cleanest illustration. Greene, a former Stratton Oakmont executive, sued Paramount Pictures and others over the character Nicky "Rugrat" Koskoff for defamation and invasion of privacy. At the district court stage in the Eastern District of New York, in a ruling reported in October 2015 and before his public figure status was settled, the court applied New York's private figure standard, which asks whether the publisher acted in a "grossly irresponsible manner" on a matter of legitimate public concern. That is a lower bar than actual malice, and the shift between the two tests is the whole ballgame.

By the time the Second Circuit affirmed summary judgment on June 11, 2020, Greene had acknowledged his public figure status, so he had to show the filmmakers actually entertained serious doubts about the truth of the portrayal or had obvious reasons to doubt its accuracy. He could not. The court also found no reasonable viewer would believe the fictional Koskoff depicted Greene: a different name, a different department, and a screenwriter's description of a composite of three different people.

The right of publicity is messier. There is no federal statute and no federal case law recognizing a general right of publicity in the United States. It exists purely under state common law and statutes, roughly half the states have a specific publicity rights statute, and states diverge on whether the right survives death. Most hold it does not. California is the exception: under Civil Code Section 3344.1, the postmortem right runs 70 years after death, covers a deceased personality's name, voice, signature, photograph, or likeness (chiefly in merchandise and advertising), and is a freely transferable, licensable, descendible property right. The person must have been domiciled in California at death, and the rights holder must register the claim with the California Secretary of State before recovering damages for any use predating registration.

Sometimes the case never reaches a standard at all. In October 1999, Lana Tisdel sued Fox Searchlight Pictures and the producers of Boys Don't Cry in federal court, alleging defamation, invasion of privacy, and unauthorized use of her name and likeness, claiming the film falsely depicted her as habitually intoxicated, promiscuous, and present during the killings. It settled out of court in March 2000 on undisclosed terms. Settlements are not precedent, but they are cost, and cost is what the people financing your movie are pricing.

Why the First Amendment Protects Docudramas, Sometimes

The strongest authority on the creative side is Olivia de Havilland's suit against FX Networks over her portrayal by Catherine Zeta-Jones in Feud: Bette and Joan, alleging violation of her statutory right of publicity, misappropriation, false light invasion of privacy, and unjust enrichment. In a ruling dated March 26, 2018, the California Court of Appeal reversed the trial court and rejected the claims under the state's anti-SLAPP statute, holding the docudrama a creative work entitled to full First Amendment protection. The U.S. Supreme Court declined to hear her appeal on January 7, 2019, leaving that ruling standing.

Two pieces of the reasoning matter. On publicity, the court applied transformative use: where the value of the work comes principally from some source other than the celebrity's fame, here the skill of the creators and performers, the work carries enough transformative elements to earn First Amendment protection over a right of publicity claim. On false light, audiences expect docudramas to take certain creative liberties, so minor factual alterations are not actionable when the overall portrayal remains substantially truthful.

The working rule: protection attaches to work that is genuinely creative and substantially truthful in its overall impression, not to a fabricated, materially damaging accusation dressed up as dramatization.

Which is why the heading says sometimes. Protection is not immunity from being sued, only from losing. In December 2019, the parent company of the Atlanta Journal-Constitution sent a letter to Warner Bros. and director Clint Eastwood threatening a defamation suit over Richard Jewell and its depiction of reporter Kathy Scruggs, who died in 2001, specifically the unsupported suggestion that she traded sex with an FBI agent for a news tip. The company demanded a disclaimer acknowledging dramatization. Warner Bros. called the claims baseless and said it stood behind the film as based on credible source material. That is a demand letter and a public fight, not an adjudicated outcome. The lesson is not who was right. It is that one invented, sourceless, deeply damaging beat about a real named person generates the letter, and letters cost money whether or not they ripen into anything.

The Insurance Company That Actually Decides Whether Your Sale Closes

Here is the part that surprises writers. The entity with the most practical veto power over a true story film is not a studio lawyer. It is an errors and omissions underwriter.

E&O insurance is required for essentially every project intended for distribution. Studios, television and cable networks, home video, and internet and streaming platforms typically demand proof of coverage before releasing a film, and some festivals require it before they will screen one. The policy covers precisely the risk categories a true story raises: theft of idea, copyright infringement, libel, slander, invasion of privacy, defamation, right of publicity, and false light. Not a coincidence. E&O exists because these are the claims films attract.

So the underwriter's questionnaire becomes the real rights audit. Where did each factual assertion come from? Which characters depict identifiable living people? Which of those are private figures? What releases exist? A project that cannot answer cleanly does not get coverage on normal terms, and without coverage the distribution deal does not close. That is why marketplaces weigh rights clearance and E&O readiness alongside craft when they judge whether a true story script is sellable, on platforms like ScriptLix and inside every acquisitions department that has ever had a release date slip.

Cost is not a fixed rate card, and be suspicious of anyone quoting one. Independent industry sources put the broad range at roughly $1,000 to $20,000 and up depending on budget, distribution reach, and content risk, with real people's stories named explicitly as a risk driver. Wrapbook cites $2,500 to $10,000 for a standard three year term on an independent project. Toby Hansen Insurance Agency breaks it into tiers, from roughly $1,000 to $3,000 for small independents under $100K in budget, up to $15,000 to $30,000 and beyond for $5M plus films with international streaming distribution. Those are brokers' published estimates, useful for scale, not an official schedule.

Commonly cited limits are around $1 million per claim and $3 million aggregate, higher where a distributor demands it, with one source citing a roughly $10,000 deductible as typical. Policies usually run three years, meant to span the window when most post release claims arise, with tail extensions for distribution that continues past it.

One exclusion matters more than all the pricing. E&O policies exclude intentional misconduct, fraud, and criminal activity, so a filmmaker who knowingly defames a subject is not covered. Insurance protects a good faith mistake in a carefully sourced project, not something you knew was false about a real person.

Can You Sell a Screenplay Based on a True Story Without Getting Sued?

You cannot make the risk zero. You can make it small and, more importantly, legible to a buyer. That second part turns a risky spec into a purchasable one.

Build from the public record and keep the file. Court filings, contemporaneous news coverage, published interviews, government documents, transcripts. Maintain a source list keyed to the scenes and lines it supports. This is the highest leverage habit in true story writing: when the clearance questionnaire arrives you already have the answers instead of a memory of a website you read in March.

Fictionalize on purpose, not by accident. The composite is the workhorse technique, and Greene shows why: a different name, a different department, a screenwriter's composite of three people. Composites work when they dissolve identifying detail. They fail when you change a name and leave every other identifier intact.

Treat disclaimers as one factor, never a shield. In Greene, the court noted the filmmakers had taken appropriate steps to ensure no one would be defamed: vetting procedures, consulting source material, the screenwriter's assurance that characters were fictionalized composites, and an onscreen disclaimer stating that certain characters were fictionalized or invented for purposes of dramatization. The disclaimer sat inside that list as evidence of care, not a legal force field. A script leaning on the card alone has not done the work.

Get releases where they are cheap and the exposure is real. Private figures sue under a lower standard than public figures, so the unflattering depiction of a living private individual is where a signed release buys the most peace per dollar. A public official acting in an official capacity is a different calculation.

Never hang the most damaging accusation in the film on a single uncorroborated source. That is the beat that draws the letter, as the Richard Jewell dispute illustrates. If you cannot corroborate it, cut it or invent around it clearly enough that it attaches to no identifiable person.

Talk to a lawyer before the sale, not after. Rights clearance is cheap early and expensive once a start date exists.

When You Don't Need Life Rights at All

Plenty of true story projects proceed without a life rights agreement, and the categories are predictable.

Events in the public record involving public officials acting in their public roles are the clearest case. Facts are not copyrightable, and the actual malice standard from Sullivan gives real breathing room on portrayals of officials and public figures. The same logic extends to limited purpose public figures, people who voluntarily stepped into a specific public controversy, the profile of most people at the center of a story worth dramatizing.

Historical material where every participant is long dead is the second case. Defamation and invasion of privacy die with the subject under the traditional common law torts. The residual question is publicity rights, which most states do not extend past death, though California's postmortem statute is the exception, particularly for a subject domiciled there.

The third case is the one people forget: your own story. You already hold the releases that matter for yourself. What you do not hold are the releases for everyone else in it, and memoir adaptations tend to fail clearance review on the supporting cast rather than the protagonist.

One last piece of realism. Not needing life rights legally is different from a buyer not wanting them. Producers chase cooperation because it delivers access, publicity, and a marketing position no unauthorized version can claim, and because a signed covenant not to sue is cheaper than defending a suit you would probably win. If your subject is alive and the story hangs on private material only they possess, get the agreement. If your subject is a public figure at the center of a documented public event, write it, source it, and take the position the case law supports.

So, can you sell a screenplay based on a true story? Yes. Sell it as a script whose rights position is already mapped, and you are not selling a legal problem anymore. You are selling a solved one.